SMO and steatosis: In addition to these results in vivo, the inhibition of Hh signaling in cultured mouse and human hepatocytes using the SMO inhibitor cyclopamine (Hovhannisyan et al., 2009) also resulted in marked steatosis within 48 to 72 hr (Figure 2—figure supplement 3).